Should a stellate ganglion block be performed before or concurrently with eating disorder therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stellate Ganglion Block and Eating Disorder Therapy: No Evidence for Combined Use

There is no established role for stellate ganglion block (SGB) in the treatment of eating disorders, and it should not be performed either before or concurrently with eating disorder therapy. The available evidence does not support any connection between SGB and eating disorder treatment.

Why This Question Reflects a Misunderstanding

The stellate ganglion block is a sympathetic nerve block used for specific conditions related to sympathetic hyperactivity, including:

  • Post-traumatic stress disorder (PTSD), where SGB reduced CAPS-5 symptom severity scores by 12.6 points compared to 6.1 points with sham treatment over 8 weeks 1
  • Anxiety disorders, where SGB decreased GAD-7 scores by 9.0 points at 1 week and 8.3 points at 1 month, with approximately 75-80% of patients showing clinically meaningful improvement 2
  • Chronic regional pain syndrome (CRPS) and other sympathetically-mediated pain conditions 3

The proposed mechanism involves reducing nerve growth factor (NGF) and subsequently lowering norepinephrine levels, which addresses sympathetic overdrive 3, 4. This mechanism has no relevance to the core pathophysiology of eating disorders.

Evidence-Based Treatment for Eating Disorders

The actual treatment approach for eating disorders is entirely different and well-established:

For Adolescents and Emerging Adults

  • Family-based treatment (FBT) is the first-line psychotherapy for adolescents with anorexia nervosa and bulimia nervosa who have an involved caregiver 5, 6
  • FBT achieves a remission rate of 48.6% at 6-12 months compared to 34.3% with individual treatment (OR 2.08; 95% CI 1.07-4.03) 6

For Adults with Bulimia Nervosa

  • Eating disorder-focused cognitive-behavioral therapy (CBT) combined with fluoxetine 60 mg daily should be prescribed either initially or if minimal response to psychotherapy alone occurs by 6 weeks 5

For Adults with Anorexia Nervosa

  • Eating disorder-focused psychotherapy that normalizes eating behaviors, restores weight, and addresses psychological aspects including fear of weight gain and body image disturbance 5

For Binge-Eating Disorder

  • Eating disorder-focused CBT or interpersonal therapy, delivered in individual or group formats 5

The Multidisciplinary Approach Required

All patients with eating disorders require a coordinated treatment plan incorporating:

  • Medical monitoring including vital signs, weight, BMI, and laboratory assessment (CBC, comprehensive metabolic panel, ECG for those with restrictive eating or severe purging) 5, 6
  • Psychiatric evaluation for co-occurring conditions including depression, anxiety, and suicidality 5
  • Nutritional rehabilitation with individualized weight gain goals and careful refeeding to prevent refeeding syndrome 5, 6
  • Disorder-specific psychotherapy as the cornerstone of treatment 5

Important Clinical Caveat

If a patient with an eating disorder also has comorbid PTSD or severe anxiety disorder, these conditions should be assessed and treated as separate entities. In such cases, SGB might be considered as an adjunctive treatment specifically for the PTSD or anxiety symptoms 1, 2, but this would be entirely independent of and unrelated to the eating disorder treatment itself. The eating disorder would still require the standard evidence-based approaches outlined above 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.